STLN Starling Oncology, Inc.
$6.29▼ -6.26%
Healthcare
Other
Pre-market
$6.36▲ +1.16%
Oct 27, 7:52 AM ET
Volume 1.86M
Avg Volume (10D) 1.29M
Key Metrics & Fundamentals
Market Cap
$641.05M
P/E Ratio
–
Div Yield
0.00%
52W Range
2.32 - 7.13
% vs 50 MA
-2.64%
% vs 200 MA
35.58%
RSI-14
45.6
MACD Histogram
-0.0200
Beta (1Y vs SPY)
1.60
Free Cash Flow
$11.03M
Gross Rev
$161.28M
Gross Profit
$27.17M
EBITDA
-$2.86M
COGS
$134.12M
Operating Exp
$31.78M
Operating Income
-$4.62M
EBIT
-$4.62M
Pretax Income
-$9.79M
Net Income
-$9.79M
EPS (Diluted)
-0.08
Price & Volume History
Loading chart…
Recent News

Starling Oncology Announces Third Quarter 2026 Earnings Release Date and Conference Call
GlobeNewswire · Oct 26, 2026 9:00 AM ET

Starling Oncology (STLN) Stock Gets Fair Value Boost On Capitated Revenue And Nexus Views
Simply Wall St. · Oct 15, 2026 7:22 PM ET

Starling Oncology Leadership Highlights Recent and Upcoming Industry Conference Participation
GlobeNewswire · Oct 1, 2026 4:14 PM ET

Starling Oncology to Participate in Wells Fargo Healthcare Conference
GlobeNewswire · Aug 24, 2026 9:00 AM ET
Oncology Institute Q2 Earnings Call Highlights
MarketBeat · Aug 7, 2026 2:04 PM ET
The Oncology Institute, Inc. (STLN) Reports Q2 Loss, Tops Revenue Estimates
Zacks · Aug 6, 2026 7:10 PM ET
Starling Oncology Reports Second Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance
GlobeNewswire · Aug 6, 2026 4:14 PM ET
Starling Oncology Reports Second Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance
GlobeNewswire · Aug 6, 2026 4:14 PM ET
Earnings To Watch: Starling Oncology Inc (STLN) Q2 2026 -- GF Value Sees 44% Downside
GuruFocus.com · Aug 5, 2026 9:37 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See STLN's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.